YMS R19 Med Policies
Policy Documents
 
Policies
 
Policies By Category
Part A
Part B
NCD
HHH MAC
DME MAC
MedicareBlue
 
News & Announcements
 
User Information
 
Search Instructions
Policies
Search within, 'NCD'
(FDG) PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers - 220.6.14
(FDG) PET for Colorectal Cancer - 220.6.4
24-Hour Ambulatory Esophageal pH Monitoring - 100.3
Abarelix for the Treatment of Prostate Cancer - 110.19
Abortion - 140.1
Acupuncture - 30.3
Acupuncture for Fibromyalgia - 30.3.1
Acupuncture for Osteoarthritis - 30.3.2
Adult Liver Transplantation - 260.1
Air-Fluidized Bed - 280.8
Alpha-fetoprotein (AFP) - 190.25
Ambulatory Blood Pressure Monitoring - 20.19
Ambulatory EEG Monitoring - 160.22
Anesthesia in Cardiac Pacemaker Surgery - 10.6
Anti-Cancer Chemotherapy for Colorectal Cancer - 110.17
Anti-Inhibitor Coagulant Complex (AICC) - 110.3
Antigens Prepared for Sublingual Administration - 110.9
Apheresis (Therapeutic Pheresis) - 110.14
Aprepitant for Chemotherapy-Induced Emesis - 110.18
Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee - 150.9
Artificial Hearts and Related Devices - 20.9
Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy - 160.7.1
Autogenous Epidural Blood Graft - 10.5
Bariatric Surgery for Treatment of Morbid Obesity - 100.1
Biofeedback Therapy - 30.1
Biofeedback Therapy for the Treatment of Urinary Incontinence - 30.1.1
Bladder Stimulators (Pacemakers) - 230.16
Blood-Derived Products for Chronic Non-Healing Wounds - 270.3
Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors - 110.20
Blood Counts - 190.15
Blood Glucose Testing - 190.20
Blood Platelet Transfusions - 110.8
Blood Transfusions - 110.7
Bone (Mineral) Density Studies - 150.3
Breast Reconstruction Following Mastectomy - 140.2
Carcinoembryonic Antigen (CEA) - 190.26
Cardiac Catheterization Performed in Other than a Hospital Setting - 20.25
Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB) - 20.16
Cardiac Pacemaker Evaluation Services - 20.8.1
Cardiac Pacemakers - 20.8
Cardiac Rehabilitation Programs - 20.10
Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test - 20.27
Carotid Body Resection/Carotid Body Denervation - 20.18
Carotid Sinus Nerve Stimulator - 160.6
Cavernous Nerves by Electrical Stimulation with Penile Plethysmography - 160.26
Cellular Therapy - 30.8
Certain Drugs Distributed by the National Cancer Institute - 110.2
Challenge Ingestion Food Testing - 110.12
Chelation Therapy for Treatment of Atherosclerosis - 20.21
Chemical Aversion Therapy for Treatment of Alcoholism - 130.3
Closed-Loop Blood Glucose Control Device (CBGCD) - 40.3
Cochlear Implantation - 50.3
Cochleostomy with Neurovascular Transplant for Meniere's Disease - 50.7
Collagen Crosslinks, any Method - 190.19
Collagen Meniscus Implant - 150.12
Colonic Irrigation - 100.7
Colorectal Cancer Screening Tests - 210.3
Computed Tomography - 220.1
Computer Enhanced Perimetry - 80.9
Consultation Services Rendered by a Podiatrist in a Skilled Nursing Facility - 70.2
Consultations with a Beneficiary's Family and Associates - 70.1
Continuous Positive Airway Pressure (CPAP) Therapy For Obstructive Sleep Apnea (OSA) - 240.4
Corset Used as Hernia Support - 280.11
Counseling to Prevent Tobacco Use - 210.4.1
Cryosurgery of Prostate - 230.9
Cytogenetic Studies - 190.3
Cytotoxic Food Tests - 110.13
Deep Brain Stimulation for Essential Tremor and Parkinson's Disease - 160.24
Dental Examination Prior to Kidney Transplantation - 260.6
Dermal Injections for Treatment of Facial Lipodystrophy Syndrome (LDS) - 250.5
Diabetes Outpatient Self-Management Training - 40.1
Diagnosis and Treatment of Impotence - 230.4
Diagnostic Breath Analyses - 100.5
Diagnostic Endocardial Electrical Stimulation (Pacing) - 20.12
Diagnostic Pap Smears - 190.2
Diathermy Treatment - 150.5
Digital Subtraction Angiography - 220.9
Digoxin Therapeutic Drug Assay - 190.24
Dimethyl Sulfoxide (DMSO) - 230.12
Displacement Cardiography - 20.24
Durable Medical Equipment Reference List - 280.1
Electrical Aversion Therapy for Treatment of Alcoholism - 130.4
Electrical Continence Aid - 230.15
Electrical Nerve Stimulators - 160.7
Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of Wounds - 270.1
Electrocardiographic (EKG) Services - 20.15
Electroencephalographic (EEG) Monitoring During Surgical Procedures Involving the Cerebral Vasculature - 160.8
Electron Microscope - 190.4
Electronecephalographic (EEG) Monitoring During Open-Heart Surgery - 160.9
Electronic Speech Aids - 50.2
Electrosleep Therapy - 30.4
Electrotherapy for Treatment of Facial Nerve Paralysis (Bell's Palsy) - 160.15
Endoscopy - 100.2
Endothelial Cell Photography - 80.8
Enteral and Parenteral Nutritional Therapy - 180.2
Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions - 110.21
Esophageal Manometry - 100.4
Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis - 20.22
Evoked Response Tests - 160.10
External Counterpulsation (ECP) for Severe Angina - 20.20
Extracorporeal Immunoadsorption (ECI) Using Protein A Columns - 20.5
Extracorporeal Photopheresis - 110.4
Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery - 20.2
Fabric Wrapping of Abdominal Aneurysms - 20.23
Fecal Occult Blood Test (FOBT) - 190.34
Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders - 150.8
Food Allergy Testing and Treatment - 110.11
Gamma Glutamyl Transferase (GGT) - 190.32
Gastric Balloon for Treatment of Obesity - 100.11
Gastric Freezing - 100.6
Gastrophotography - 100.12
Glycated Hemoglobin/Glycated Protein - 190.21
Granulocyte Transfusions - 110.5
Gravlee Jet Washer - 230.5
Hair Analysis - 190.6
Heart Transplants - 260.9
Heartsbreath Test for Heart Transplant Rejection - 260.10
Heat Treatment, including the Use of Diathermy and Ultrasound for Pulmonary Conditions - 240.3
Hemodialysis for Treatment of Schizophrenia - 130.8
Hemorheograph - 250.2
Hepatitis Panel/Acute Hepatitis Panel - 190.33
HIS Bundle Study - 20.13
Histocompatibility Testing - 190.1
Home Blood Glucose Monitors - 40.2
Home Health Nurses' Visits to Patients Requiring Heparin Injection - 290.2
Home Health Visits to a Blind Diabetic - 290.1
Home Oxygen Use to Treat Cluster Headache - 240.2.2
Home Prothrombin Time INR Monitoring for Anticoagulation Management - 190.11
Home Use of Oxygen - 240.2
Home Use of Oxygen in Approved Clinical Trials - 240.2.1
Hospital and Skilled Nursing Facility Admission Diagnostic Procedures - 70.5
Hospital Beds - 280.7
Human Chorionic Gonadotropin (hCG) - 190.27
Human Immunodeficiency Virus (HIV) Testing (Diagnosis) - 190.14
Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) - 190.13
Human Tumor Stem Cell Drug Sensitivity Assays - 190.7
Hydrophilic Contact Lens For Corneal Bandage - 80.1
Hydrophilic Contact Lenses - 80.4
Hyperbaric Oxygen Therapy - 20.29
Hyperthermia for Treatment of Cancer - 110.1
Implantable Automatic Defibrillators - 20.4
Implantation of Anti-Gastroesophageal Reflux Device - 100.9
Incontinence Control Devices - 230.10
Independence iBOT 4000 Mobility System - 280.15
Induced Lesions of Nerve Tracts - 160.1
Infrared Therapy Devices - 270.6
Infusion Pumps - 280.14
Injection Sclerotherapy for Esophageal Variceal Bleeding - 100.10
Inpatient Hospital Pain Rehabilitation Programs - 10.3
Inpatient Hospital Stays for Treatment of Alcoholism - 130.1
Institutional and Home Care Patient Education Programs - 170.1
Insulin Syringe - 40.4
Intensive Behavioral Therapy for Cardiovascular Disease - 210.11
Intensive Cardiac Rehabilitation (ICR) Programs - 20.31
Intestinal and Multi-Visceral Transplantation - 260.5
Intestinal Bypass Surgery - 100.8
Intraocular Lenses (IOLs) - 80.12
Intraocular Photography - 80.6
Intraoperative Ventricular Mapping - 20.11
Intrapulmonary Percussive Ventilator (IPV) - 240.5
Intravenous Histamine Therapy - 30.6
Intravenous Immune Globulin for the Treatment of Autoimmune Mucocutaneous Blistering Diseases - 250.3
Intravenous Iron Therapy - 110.10
Invasive Intracranial Pressure Monitoring - 160.14
Islet Cell Transplantation in the Context of a Clinical Trial - 260.3.1
L-Dopa - 160.17
Laboratory Tests - CRD Patients - 190.10
Laetrile and Related Substances - 30.7
Laparoscopic Cholecystectomy - 100.13
Laser Procedures - 140.5
Levocarnitine for use in the Treatment of Carnitine Deficiency in ESRD Patients - 230.19
Lipid Testing - 190.23
Lumbar Artificial Disc Replacement (LADR) - 150.10
Lung Volume Reduction Surgery (Reduction Pneumoplasty) - 240.1
Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine) - 260.7
Lymphocyte Mitogen Response Assays - 190.8
Magnetic Resonance Angiography (MRA) - 220.3
Magnetic Resonance Imaging (MRI) - 220.2
Magnetic Resonance Spectroscopy (MRS) - 220.2.1
Mammograms - 220.4
Manipulation - 150.1
Medical Nutrition Therapy - 180.1
Melodic Intonation Therapy - 170.2
Microvolt T-Wave Alternans (MTWA) - 20.30
Mobility Assistive Equipment (MAE) - 280.3
Multiple Electroconvulsive Therapy (MECT) - 160.25
Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases - 200.2
Nesiritide for Treatment of Heart Failure Patients - 200.1
Neuromuscular Electrical Stimulation (NMES) - 160.12
Non-Implantable Pelvic Floor Electrical Stimulator - 230.8
Noncontact Normothermic Wound Therapy (NNWT) - 270.2
Noninvasive Tests of Carotid Function - 20.17
Nonselective (Random) Transfusions and Living-Related Donor-Specific Transfusions (DST) in Kidney Transplantation - 110.16
Nuclear Radiology Procedure - 220.8
Obsolete or Unreliable Diagnostic Tests - 300.1
Ocular Photodynamic Therapy (OPT) - 80.2
Ornish Program for Reversing Heart Disease - 20.31.2
Osteogenic Stimulators - 150.2
Outpatient Hospital Pain Rehabilitation Programs - 10.4
Outpatient Hospital Services for Treatment of Alcoholism - 130.2